Proteomic analysis of chemonaïve pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets

Journal of Proteome Research

Volumn 8, Issue 8, 2009, Pages 3882-3888

  Folio, Cecilia ^a   Mora, María I ^b   Zalacain, Marta ^a   Corrales, Fernando J ^b   Segura, Victor ^b   Sierrasesúmaga, Luis ^a   Toledo, Gemma ^c   San Julián, Mikel ^a   Patiño García, Ana ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c MD ANDERSON CANCER CENTER   (Spain)

Author keywords

CRYAB; Ezrin; Pediatric osteosarcoma; Proteomics

Indexed keywords

ALPHA CRYSTALLIN; EZRIN; CRYAB PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TUMOR PROTEIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER RESISTANCE; CHILD; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; MALIGNANT TRANSFORMATION; METASTASIS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEOMICS; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS; BONE; BONE TUMOR; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADOLESCENT; ALPHA-CRYSTALLIN B CHAIN; BONE AND BONES; BONE NEOPLASMS; CHILD; CHROMATOGRAPHY, LIQUID; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; NEOPLASM PROTEINS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PROTEOMICS; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 68549092905     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900113w     Document Type: Article

References (23)

1. Clark, J. C.; Dass, C. R.; Choong, P. F. A review of clinical and molecular prognostic factors in osteosarcoma. J. Cancer Res. Clin. Oncol. 2008, 134, 281-297.
2. Kansara, M.; Thomas, D. M. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 2007, 26, 1-18.
3. Gorlick, R.; Anderson, P.; Andrulis, I.; et al. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin. Cancer Res. 2003, 9, 5442-5453.
4. Ferrari, S.; Palmerini, E. Adjuvant and neoadyuvant combination chemotherapy for osteogenic sarcoma. Curr. Opin. Oncol. 2007, 19, 341-346.
5. Bridge, J. A.; Nelson, M.; McComb, E.; et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet. Cytogenet. 1997, 95, 74-87.
6. Atiye, J.; Wolf, M.; Kaur, S.; et al. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes, Chromosomes Cancer 2005, 42, 158-163.
7. Sandberg, A. A.; Bridge, J. A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet. Cytogenet. 2003, 145, 1-30.
8. Li, Y.; Dang, T. A.; Shen, J.; Perlaky, L.; Hicks, J.; Murray, J.; Meyer, W.; Chintagumpala, M.; Lau, C. C.; Man, T. K. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics 2006, 6, 3426-3435.
9. Kawai, A.; Kondo, T.; Suehara, Y.; Kikuta, K.; Hirohashi, S. Global protein-expression analysis of bone and soft tissue sarcomas. Clin. Orthop. Relat. Res. 2008, 466, 2099-2106.
10. Lecanda, F.; Avioli, L. V.; Cheng, S. L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 1997, 67, 386-396.
11. Patiño-Garcia, A., Zalacain, M., Folio, C., Zandueta, C., Sierrasesumaga, L., San Julian, M., Toledo, G., De Las Rivas, J., Lecanda, F. Profiling of chemonaïve osteosarcoma and paired-normal cells identifies EBF2 as a mediator of OPG inhibition to TRAIL-induced apoptosis. Clin. Cancer Res., accepted for publication.
12. Lecanda, F.; Warlow, P. M.; Sheikh, S.; Furlan, F.; Steinberg, T. H.; Civitelli, R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J. Cell Biol. 2000, 151, 931-944.
13. Santamaria, E.; Avila, M. A.; Latasa, M. U.; Rubio, A.; Martin-Duce, A.; Lu, S. C.; Mato, J. M.; Corrales, F. J. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3065-3070.
14. Irizarry, R. A.; Bolstad, B. M.; Collin, F.; Cope, L. M.; Hobbs, B.; Speed, T. P. Summaries of affymetrix genechip probe level data. Nucleic Acids Res. 2003, 31, e15.
15. Smyth G. K. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor; Gentleman, R., Carey, V., Dudoit, S., Irizarry, R., Huber, W., Eds.; Springer: New York, 2005; pp 397-420.
16. Sturn, A.; Quackenbush, J.; Trajanoski, Z. Genesis: Cluster analysis of microarray data. Bioinformatics 2002, 18, 207-208.
17. Segura, V.; Podhorski, A.; Guruceaga, E.; Sevilla, J. L.; Mato, J. M.; Corrales, F. J.; Rubio, A. GARBAN II: An integrative framework for extracting biological information from proteómica and genomic data. Proteomics 2006, 6, S12-S15.
18. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
19. Li, Q.; Wu, M.; Wang, H.; Xu, G.; Zhu, T.; Zhang, Y.; Liu, P.; Song, A.; Gang, C.; Han, Z.; Zhou, J.; Meng, L.; Lu, Y.; Wang, S.; Ma, D. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2008, 261 (1), 55-63.
20. Fais, S. A role for ezrin in a neglected metastatic tumor function. Trends Mol. Med. 2004, 10, 249-250.
21. Salas, S.; Bartoli, C.; Deville, J. L.; Gaudart, J.; Fina, F.; Calisti, A.; Bollini, G.; Curvale, G.; Gentet, J. C.; Duffaud, F.; Figarella-Branger, D.; Bouvier, C. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas. Virchows Arch. 2007, 451, 999-1007.
22. Kim, M. S.; Song, W. S.; Cho, W. H.; Lee, S. Y.; Jeon, D. G. Ezrin expression predicts survival in stage IIB osteosarcomas. Clin. Orthop. Relat. Res. 2007, 459, 229-236.
23. Kamradt, M. C.; Lu, M.; Werner, M. E.; Kwan, T.; Chen, F.; Strohecker, A.; Oshita, S.; Wilkinson, J. C.; Yu, C.; Oliver, P. G.; Duckett, C. S.; Buchsbaum, D. J.; LoBuglio, A. F.; Jordan, V. C.; Cryns, V. L. The small heat shock protein alpha B-Crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J. Biol. Chem. 2005, 280, 11059-11066.